Italia markets closed

BMY Jan 2026 38.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,10000,0000 (0,00%)
Alla chiusura: 11:51AM EDT
Schermo intero
Chiusura precedente3,1000
Aperto3,1000
Denaro2,7400
Lettera3,0000
Prezzo d'esercizio38,00
Scadenza2026-01-16
Min-Max giorno3,1000 - 3,1000
Contratto - Min-MaxN/D
Volume13
Open Interest778
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri